Has Steven Conant received payments from drug or device companies?

Yes. Drug and device makers reported $2,601 in general payments to Steven Conant across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Conant did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Conant come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Conant

Psychiatry · Avon, INNPI 1871569772

Payments from drug & device makers

$2,601in general payments, 2019–2025

Across 132 payments — averaging $19.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$489
Vanda Pharmaceuticals Inc.$309
Otsuka America Pharmaceutical, Inc.$294
Neurocrine Biosciences, Inc.$282
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$279
Teva Pharmaceuticals USA, Inc.$279
plus $668 from 9 others

What the payments were for

Food & beverage$2,45494%
Education$1476%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	29	$489
Vanda Pharmaceuticals Inc.	13	$309
Otsuka America Pharmaceutical, Inc.	9	$294
Neurocrine Biosciences, Inc.	20	$282
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$279
Teva Pharmaceuticals USA, Inc.	11	$279
Alkermes, Inc.	12	$222
Johnson & Johnson	5	$97
Lundbeck LLC	5	$96
Indivior Inc.	5	$91
E.r. Squibb & Sons, L.L.C.	2	$45
Tris Pharma Inc	2	$35
Takeda Pharmaceuticals U.S.A., Inc.	2	$31
Corium, LLC	2	$30
Axsome Therapeutics, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ABILIFY MAINTENA$122
ABILIFY ASIMTUFII$122

How this compares

$2,601 in reported general payments places this provider in the 75th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
FanaptIloperidone	37	$83,570
Invega SustennaPaliperidone Palmitate	29	$77,412
VraylarCariprazine Hcl	42	$67,309
RexultiBrexpiprazole	24	$35,408
CaplytaLumateperone Tosylate	17	$29,317
Lurasidone Hcl	71	$28,806
Risperdal ConstaRisperidone Microspheres	15	$25,697
TrintellixVortioxetine Hydrobromide	47	$24,716
Aripiprazole	104	$7,303
Chlorpromazine Hcl	17	$6,714
Paliperidone ErPaliperidone	20	$4,870
Ziprasidone Hcl	79	$3,811
Quetiapine Fumarate ErQuetiapine Fumarate	35	$3,713
Oxcarbazepine	45	$3,256
Divalproex Sodium ErDivalproex Sodium	34	$3,171

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta	$97	$103,10944 claims
Vanda Pharmaceuticals Inc.Fanapt	$309	$83,57037 claims
AbbVieVraylar	$489	$67,30942 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$294	$35,40824 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$279	$29,31717 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$31	$24,71647 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Avon

Steven PaulCarmel$2.9M
Jay FawverAngola$1.4M
Suhayl NasrMichigan City$788K
Christopher BojrabCarmel$714K
Joseph FanelliMunster$443K
Anantha ShekharIndianapolis$433K
Eric JaggersJeffersonville$260K
Larry LambertsonFort Wayne$208K
Elizabeth MartinMarion$159K
Leslie HulvershornIndianapolis$159K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →